Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.
Home Search
AI - search results
If you're not happy with the results, please do another search
Novel digital biomarkers to aid in the diagnosis and tracking of symptoms in patients...
Dr Rutger Zietsma – CEO at Manus Neurodynamica Ltd – and PD Dr Angela Deutschländer share their vision on earlier diagnosis and objective symptom tracking with the NeuroMotor PenTM.
Push-pull tech for sustainable agricultural intensification in East Africa
The UPSCALE project aims to achieve food security in sub-Saharan Africa by using nature-based solutions inspired by push-pull technology to close the yield gap in smallholder agriculture.
Disproportionate air pollution exposure in African-American communities
We spoke to Elica M. Moss from Alabama A&M University to profile her research on disproportionate air pollution exposure in African-American communities with the Deep South Center for Environmental Justice.
Realising sustainable agriculture post-pandemic
Open Access Government highlights the priorities of Japan’s Agriculture, Forestry and Fisheries Research Council, as it supports workers through COVID-19 and works towards sustainability goals.
Hitting your sustainable targets need not cost the earth
Nigel Penny, Video Collaboration Specialist at Logitech UK & IRL offers some advice on how UK public sector organisations can meet their increasing government set green targets much more efficiently.
How AI is levelling the playing field when it comes to gender and healthcare
Charles Taylor, Founder and Chief Technology Officer at HeartFlow, explores how artificial intelligence (AI) is helping to fix the gender disparities in healthcare.
The role of MFDs, photocopiers and printers in the 2021 sustainable office
Dave Crispin, CEO of Crispin Associates (UK) Ltd, presents the latest article around the role MFDs, photocopiers and printers play in the “sustainable” 2021 office.
Sustainable business models for a greener Europe
Open Access Government brings to light the essential role of bio-based industries in Europe, charting the work of Bio-Based Industries Joint Undertaking (BBI JU).
Why AI-powered EdTech is the future of life-long learning
Aliki Constantinou, Educational Consultant, Soffos.ai, delves into the importance of debate in education and how AI-powered EdTech can enhance discursive learning.
Study finds COVID increased “forced labour” in garment supply chains
This study examined 302 factories, finding that forced labour and exploitation increased in garment supply chains across Ethiopia, Honduras, India and Myanmar.
The U.S. Environmental Protection Agency: Protecting the air we breathe
In an interview with Open Access Government, the U.S. Environmental Protection Agency’s Tim Carroll offers a fascinating insight into the current and future state of U.S. air quality.
What future for sustainable permanent grasslands in Europe?
Paul Newell Price of ADAS reflects on the future of permanent grasslands (PG) in Europe within the frame of the Horizon 2020 SUPER-G Project.
CIRCLES: Microbiome research for healthy and sustainable food systems
Here we learn all about Horizon 2020 funded Project CIRCLES, which provides the scientific knowledge to exploit natural microbiomes for the sustainable food production, delivering new and healthier food applications.
CBD oil for pain: What the research shows
Oils by Simpson of 2012 supplies organic full-spectrum CBD cannabis oil products. CBD oil is popular and commonly used for its potent therapeutic benefits, but what about its effect on pain? Here’s what the research shows.
Soraya Rodriguez (Renew Europe- Spain) – European Parliament Mental Health Europe
https://www.mhe-sme.org/
#MHEPCoalition
PHE study finds AstraZeneca vaccine 92% effective against Delta variant
Public Health England found that two doses of the Pfizer and AstraZeneca vaccine could still keep patients with the Delta variant out of hospital - but both are now less able to stop infection in the first place.
